Grifols(GRFS) - 2023 Q3 - Earnings Call Transcript

Grifols, S.A. (NASDAQ:GRFS) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Nuria Pascual Thomas Glanzmann Let me now walk you through how we are meeting our other commitments. Q3 was another quarter of strong revenue growth, where we also delivered a 25.1% adjusted EBITDA margin, which is a significant improvement of 480 basis points compared to Q4 '22 margin. The revenue growth was primarily driven by biopharma and our flagship franchises, immunoglobulin and albumin, and we expect that moment ...